Jan Anderl
Impact in
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 8
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Heinz Faulstich (3 shared papers)Ingrid Herr (1 shared paper)Gerhard Moldenhauer (1 shared paper)Alexei V. Salnikov (1 shared paper)Christian Lutz (2 shared papers)Ulrike Litzenburger (1 shared paper)Eva Tolosa (1 shared paper)Christiane A. Opitz (1 shared paper)
- Journals
- Cancer Research (5 papers)Bioconjugate Chemistry (4 papers)Nature (2 papers)Journal of Pharmaceutical Sciences (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Jan Anderl
18 papers receiving 774 citations
Peers
Comparison fields: 5 of 80
- Genetics 209
- Oncology 307
- Radiology, Nuclear Medicine and Imaging 194
- Immunology 160
- Biological Psychiatry 17
Countries citing papers authored by Jan Anderl
This map shows the geographic impact of Jan Anderl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Anderl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Anderl more than expected).
Fields of papers citing papers by Jan Anderl
This network shows the impact of papers produced by Jan Anderl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Anderl. The network helps show where Jan Anderl may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Anderl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 260 | |
| 2 | 2015 | 168 | |
| 3 | 2012 | 154 | |
| 4 | 2013 | 58 | |
| 5 | 2020 | 42 | |
| 6 | 2012 | 31 | |
| 7 | 2021 | 24 | |
| 8 | 2022 | 16 | |
| 9 | 2014 | 11 | |
| 10 | 2023 | 9 | |
| 11 | 2014 | 7 | |
| 12 | 2011 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2021 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2015 | 1 |
About Jan Anderl
Jan Anderl is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 801 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (8 papers), Toxin Mechanisms and Immunotoxins (3 papers), RNA Interference and Gene Delivery (3 papers), Glycosylation and Glycoproteins Research (3 papers), RNA and protein synthesis mechanisms (2 papers), Silymarin and Mushroom Poisoning (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Genetics (209 citations), Oncology (307 citations), Radiology, Nuclear Medicine and Imaging (194 citations), Immunology (160 citations) and Biological Psychiatry (17 citations). Jan Anderl has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Heinz Faulstich, Ingrid Herr, Gerhard Moldenhauer, Alexei V. Salnikov, Christian Lutz, Ulrike Litzenburger, Eva Tolosa, Christiane A. Opitz, Michael Platten and Isabel Tritschler. Their work appears in journals such as Cancer Research, Bioconjugate Chemistry, Nature, Journal of Pharmaceutical Sciences and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.